Femasys (FEMY) Capital Expenditures (2020 - 2026)
Femasys posted quarterly Capital Expenditures of $79138.0 for Q1 2026, down 18.08% year-on-year from $96605.0 in Q1 2025, and down 43.41% on a QoQ basis from $139840.0 in Q4 2025.
Femasys (FEMY) has 7 years of Capital Expenditures data on file, last reported at $79138.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures fell 18.08% year-over-year to $79138.0; the trailing twelve-month figure through Mar 2026 stood at $507540.0 (down 36.06% YoY), and the FY2025 full-year result was $525007.0, down 31.07% from the prior year.
- Capital Expenditures for Q1 2026 stood at $79138.0, down from $139840.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $407936.0 in Q3 2024 and bottomed at $8901.0 in Q1 2023.
- The 5-year median for Capital Expenditures is $94229.0 (2025), against an average of $112779.0.
- The widest annual swing landed in 2023, when Capital Expenditures sank 92.61%; it then jumped 1401.48% in 2024.
- A 5-year view of Capital Expenditures shows it stood at $93877.0 in 2022, then slumped by 52.17% to $44899.0 in 2023, then soared by 137.85% to $106792.0 in 2024, then soared by 30.95% to $139840.0 in 2025, then tumbled by 43.41% to $79138.0 in 2026.
- The last three Capital Expenditures figures came in at $79138.0 (Q1 2026), $139840.0 (Q4 2025), and $194333.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 103.30 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 125.00 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 33.65 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 26.10 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 84.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 102.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 30.79 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 137.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 65.40 Mn |
| 10 | Femasys | 22.30 Mn | 16.91 Mn | - | 79,138.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79,138.00 |
| Mar 31, 2026 | 79,138.00 |
| Dec 31, 2025 | 139,840.00 |
| Dec 31, 2025 | 139,840.00 |
| Sep 30, 2025 | 194,333.00 |
| Sep 30, 2025 | 194,333.00 |
| Jun 30, 2025 | 94,229.00 |
| Jun 30, 2025 | 94,229.00 |
| Mar 31, 2025 | 96,605.00 |
| Mar 31, 2025 | 96,605.00 |
| Dec 31, 2024 | 106,792.00 |
| Dec 31, 2024 | 106,792.00 |
| Sep 30, 2024 | 407,936.00 |
| Sep 30, 2024 | 407,936.00 |
| Jun 30, 2024 | 182,421.00 |
| Jun 30, 2024 | 182,421.00 |
| Mar 31, 2024 | 64,557.00 |
| Mar 31, 2024 | 64,557.00 |
| Dec 31, 2023 | 44,899.00 |
| Dec 31, 2023 | 44,899.00 |
| Sep 30, 2023 | 27,169.00 |
| Sep 30, 2023 | 27,169.00 |
| Jun 30, 2023 | 62,948.00 |
| Jun 30, 2023 | 62,948.00 |
| Mar 31, 2023 | 8,901.00 |
| Mar 31, 2023 | 8,901.00 |
| Dec 31, 2022 | 93,877.00 |
| Dec 31, 2022 | 93,877.00 |
| Sep 30, 2022 | 18,540.00 |
| Sep 30, 2022 | 18,540.00 |
| Jun 30, 2022 | 174,690.00 |
| Jun 30, 2022 | 174,690.00 |
| Mar 31, 2022 | 120,368.00 |
| Mar 31, 2022 | 120,368.00 |
| Dec 31, 2021 | 118,623.00 |
| Dec 31, 2021 | 118,623.00 |
| Sep 30, 2021 | 175,733.00 |
| Sep 30, 2021 | 175,733.00 |
| Jun 30, 2021 | 12,512.00 |
| Jun 30, 2021 | 12,512.00 |
| Sep 30, 2020 | 3,302.00 |
| Sep 30, 2020 | 3,302.00 |